Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
Victoria Hall, Sarah Foulkes, Ferdinando Insalata, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 13, pp. 1207-1220
Open Access | Times Cited: 621

Showing 1-25 of 621 citing articles:

The current state of the art and future trends in RAS-targeted cancer therapies
Salman R. Punekar, Vamsidhar Velcheti, Benjamin G. Neel, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 10, pp. 637-655
Open Access | Times Cited: 282
Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022
Nana Wu, Keven Joyal‐Desmarais, Paula Aver Bretanha Ribeiro, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 5, pp. 439-452
Open Access | Times Cited: 187
Applications of single-cell RNA sequencing in drug discovery and development
Bram Van de Sande, Joon Sang Lee, Euphemia Mutasa-Gottgens, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 496-520
Open Access | Times Cited: 183
Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales
Utkarsh Agrawal, Stuart Bedston, Colin McCowan, et al.
The Lancet (2022) Vol. 400, Iss. 10360, pp. 1305-1320
Open Access | Times Cited: 173
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance
Katherine E. Fleming-Dutra, Amadea Britton, Nong Shang, et al.
JAMA (2022) Vol. 327, Iss. 22, pp. 2210-2210
Open Access | Times Cited: 139
Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection
Ali Zhang, Hannah D. Stacey, Michael R. D’Agostino, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 6, pp. 381-396
Open Access | Times Cited: 124
Antibody-mediated neutralization of SARS-CoV-2
Henning Gruell, Kanika Vanshylla, Timm Weber, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 925-944
Open Access | Times Cited: 117
T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 114
Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes
D. Y. Lin, Yu Gu, Yangjianchen Xu, et al.
JAMA (2022) Vol. 328, Iss. 14, pp. 1415-1415
Open Access | Times Cited: 113
Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19–Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection — United States, June 2021–February 2022
Ian D. Plumb, Leora R. Feldstein, Eric Barkley, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 15, pp. 549-555
Open Access | Times Cited: 92
Association of COVID-19 Vaccination During Pregnancy With Incidence of SARS-CoV-2 Infection in Infants
Ellen Øen Carlsen, Maria C. Magnus, Laura Oakley, et al.
JAMA Internal Medicine (2022) Vol. 182, Iss. 8, pp. 825-825
Open Access | Times Cited: 88
Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission
Michael W. Russell, Jiří Městecký
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 77
Risk of reinfection and disease after SARS‐CoV‐2 primary infection: Meta‐analysis
Maria Elena Flacco, Cecilia Acuti Martellucci, Valentina Baccolini, et al.
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 10
Open Access | Times Cited: 74
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial
Abhishek Abhishek, Rosemary J. Boyton, Nicholas Peckham, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 9, pp. 840-850
Open Access | Times Cited: 70
mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
Yu‐Shiuan Wang, Monika Kumari, Guanhong Chen, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 65
Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review
Nick Pooley, Salim S. Abdool Karim, Béhazine Combadière, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 2, pp. 367-387
Open Access | Times Cited: 63
Clinical delivery of circular RNA: Lessons learned from RNA drug development
Tiana L. Young, Kevin Chang Wang, Andrew Varley, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114826-114826
Closed Access | Times Cited: 62
Mucosal vaccines for SARS-CoV-2: triumph of hope over experience
Devaki Pilapitiya, Adam K. Wheatley, Hyon‐Xhi Tan
EBioMedicine (2023) Vol. 92, pp. 104585-104585
Open Access | Times Cited: 47
The role of immune activation and antigen persistence in acute and long COVID
Skye Opsteen, Jacob K. Files, Tim Fram, et al.
Journal of Investigative Medicine (2023) Vol. 71, Iss. 5, pp. 545-562
Open Access | Times Cited: 40
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022
Katherine E. Fleming-Dutra, Megan Wallace, Danielle Moulia, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 26, pp. 859-868
Open Access | Times Cited: 64
SARS-CoV-2 hybrid immunity: silver bullet or silver lining?
Rahul Suryawanshi, Melanie Ott
Nature reviews. Immunology (2022) Vol. 22, Iss. 10, pp. 591-592
Open Access | Times Cited: 63
Protection against Omicron from Vaccination and Previous Infection in a Prison System
Elizabeth T. Chin, David Leidner, Lauren Lamson, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 19, pp. 1770-1782
Open Access | Times Cited: 56
Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021
Jefferson M. Jones, Jean D. Opsomer, Mars Stone, et al.
JAMA (2022) Vol. 328, Iss. 3, pp. 298-298
Open Access | Times Cited: 51
Understanding “Hybrid Immunity”: Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines
Nusrat J Epsi, Stephanie A Richard, David A Lindholm, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e439-e449
Open Access | Times Cited: 46
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA–Vaccinated and Nonvaccinated Individuals in Quebec, Canada
Sara Carazo, Danuta M. Skowronski, Marc Brisson, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2236670-e2236670
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top